Company intelligence / Profile preview

VoxCell BioInnovation

Victoria, British Columbia, Canadavoxcellbio.com ↗

Ownership: Private
Employees: ~11
Development stage: Preclinical

Overview

No clinical results as the company does not develop drugs but provides advanced preclinical testing platforms. Their technology enables more predictive preclinical data by mimicking human vasculature in tissue models, aiming to reduce late-stage drug failure rates.

Therapeutic areas: Oncology
Modalities: Device (3D bioprinter)Biologic (bioinks and tissue models)Non-pharmacological therapy (tissue engineering platform for drug screening)
Industry: Non-Drug Biotech

Partnerships

Member of the "3Rs Collaborative’s MPS Technology Hub" for advancing non-animal testing technologies

Beyond the preview

Go deeper on VoxCell BioInnovation.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on VoxCell BioInnovation.

Explore the full profile